2020
DOI: 10.1016/j.arcped.2020.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in NBAS and SCYL1, genetic causes of recurrent liver failure in children: Three case reports and a literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
34
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(40 citation statements)
references
References 26 publications
6
34
0
Order By: Relevance
“…Since MIS‐C is a very rare complication of COVID‐19, the probability of a child with liver transplant developing MIS‐C should be extremely low. We present another case of MIS‐C in a liver transplant recipient, that of a 5‐year‐old boy of Comorian origin, with NBAS deficiency who received a reduced deceased donor transplant at the age of 2 years (previously reported in Chavany et al 2 ). He developed hepatic artery thrombosis postoperatively and EBV‐related lymphoproliferative disease, which resolved after immunosuppression was decreased.…”
Section: Figurementioning
confidence: 73%
“…Since MIS‐C is a very rare complication of COVID‐19, the probability of a child with liver transplant developing MIS‐C should be extremely low. We present another case of MIS‐C in a liver transplant recipient, that of a 5‐year‐old boy of Comorian origin, with NBAS deficiency who received a reduced deceased donor transplant at the age of 2 years (previously reported in Chavany et al 2 ). He developed hepatic artery thrombosis postoperatively and EBV‐related lymphoproliferative disease, which resolved after immunosuppression was decreased.…”
Section: Figurementioning
confidence: 73%
“…Seven studies reporting 16 patients from 12 unrelated families were identified (Chavany et al, 2020; Lenz et al, 2018; Li et al, 2019; Schmidt et al, 2015; Shohet et al, 2019; Smith et al, 2017; Spagnoli, Frattini, Salerno, & Fusco, 2019). Demographics, clinical features, neuroimaging and genotypes of all patients are summarized Table S1.…”
Section: Resultsmentioning
confidence: 99%
“…Previously, one patient with SCYL1 disease underwent a liver transplant at 23 months of age (Lenz et al, 2018). The majority of the patients recovered spontaneously between liver failure episodes, as early as 2 weeks after the onset and the number of episodes of acute liver failure decreased over time (Chavany et al, 2020). The acute episodes of liver failure occurred up to 8.5 years in some of the patients (Lenz et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, allogeneic liver transplantation remains a feasible treatment option for recurrent acute liver failure in NMAD. Indeed, a recent case series by Chavany et al have also described two patients who had resolution of recurrent PALF following liver transplantation 23 . However, given the phenotypic variability of NBAS deficiency, liver transplantation must be assessed on a case‐by‐case basis.…”
Section: Discussionmentioning
confidence: 99%